Navigation Links
PAREXEL Consulting Releases New Study Data on Drug Development Timelines in Safety First Era
Date:9/23/2009

g statements. The forward-looking statements in this release involve a number of risks and uncertainties. The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release. Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent restructurings; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business, including, but not limited to, the successful business integration and anticipated synergy achievements in connection with the ClinPhone acquisition; the impact on the Company's business of government regulation of the drug, medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks. Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended June 30, 2009 as filed with the SEC on August 28, 2009, which "Risk Factors" discussion is incorporated by reference in this press release. The forward-looking statements included in this press release represent the Company's estimates as of the date of this release. The Company specifically dis
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
2. PAREXEL International to Present at Robert Baird 2009 Healthcare Conference
3. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2009 Earnings Release and Conference Call
4. PAREXEL International to Present at the Wachovia Equity Conference
5. PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting
6. PAREXEL Consulting Experts To Present Insights Into Achieving Regulatory Approval at the 2009 BIO International Convention
7. PAREXEL Reports Third Quarter Fiscal Year 2009 Financial Results
8. PAREXEL Receives BioSingapore Award for Best Performing CRO
9. PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting
10. PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009
11. PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 According to Jeff Howell, Partner ... ITRA Global, new development in Downtown Toronto is expanding ... approving another 755 storeys of new development last week ... will be dominating the Toronto skyline for the foreseeable ... unquenchable thirst for new development. , As the Toronto ...
(Date:9/16/2014)... September 16, 2014 RENU 28, the world's ... became available for purchase in Australia and New Zealand ... tour beginning September 16th. The tour will make stops in ... Bundaberg on the 18th, Sydney on the 20th, and Melbourne ... Australia and New Zealand and to educate people about the ...
(Date:9/15/2014)... UPTON, NYHeat drives classical phase transitionsthink solid, ... happen when the temperature drops. If phase ... where quantum mechanics reigns, subtle fluctuations can ... from the U.S. Department of Energy,s Brookhaven ... explored this frigid landscape of absolute zero ...
(Date:9/15/2014)... 2014   Global Science & Technology, Inc. ... and services for satellite and weather systems, was ... Services (OASIS) from the General Services Administration (GSA) ... provide the government best-value solutions for complex professional ... in Pool 4. The OASIS SB award has ...
Breaking Biology Technology:ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 2ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 3Global Wellness Company Hosts ASEA Australia Tour September 16-22 2Elusive quantum transformations found near absolute zero 2Elusive quantum transformations found near absolute zero 3Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 3
... EDMONTON, Sept. 30 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ... company developing and commercializing products for the treatment ... a pipeline of late-stage immunotherapy product candidates from ... of product candidates consists of five monoclonal antibodies ...
... ... , ... (PRWEB) September 30, 2009 -- Authenware , a leading keystroke biometric developer, today ... with software-based biometric protection for its federal employees. Calculating intrinsic behavioral typing patterns ...
... Inc. (Nasdaq: BMRN ) today announced that Jean-Jacques Bienaime, ... and webcast on Wednesday, October 28, at 5:00 p.m. ET ... U.S. / Canada Dial-in Number: 800.299.6183, ... Participant Code: 51404008, Replay Dial-in Number: 888.286.8010, ...
Cached Biology Technology:Quest PharmaTech Acquires Late-Stage Immunotherapeutic Antibody Pipeline 2Quest PharmaTech Acquires Late-Stage Immunotherapeutic Antibody Pipeline 3Quest PharmaTech Acquires Late-Stage Immunotherapeutic Antibody Pipeline 4Spain's Health Ministry Contracts Authenware to Fortify System Security Prior to Flu Season 2Spain's Health Ministry Contracts Authenware to Fortify System Security Prior to Flu Season 3BioMarin to Host Third Quarter 2009 Financial Results Conference Call and Webcast on Wednesday, October 28 at 5:00 p.m. ET 2
(Date:9/15/2014)... disease (CVD) claims 17 million lives each year, while ... million. 1 New research presented by international scientists ... France on September 15, 2014, suggests that milk consumption ... At the Milk and Dairy Products in Human ... for hypertension and CVD was examined by Dr. Sabita ...
(Date:9/15/2014)... need for vitamin E and how much is enough, ... of this essential micronutrient are especially critical for the ... may become pregnant. , A lifelong proper intake of ... complicated by the fact that this nutrient is one ... It has been estimated that only a tiny fraction ...
(Date:9/12/2014)... , September 12, 2014 ... ( http://www.researchandmarkets.com/research/trs4c7/global ) has announced the addition ... Report 2014" report to their offering. ... Industry Report 2014 is a professional and ... the global fingerprint lock industry. , ,The ...
Breaking Biology News(10 mins):Dairy consumption linked to lower blood pressure and cardiovascular disease risk 2Vitamin E intake critical during 'the first 1,000 days' 2Vitamin E intake critical during 'the first 1,000 days' 3Global Fingerprint Lock Industry Report 2014 2
... compound found in cocoa, are so striking that it may ... health, reports Marina Murphy in Chemistry & Industry, the magazine ... Medical School, told C&I that epicatechin is so important that ... spent years studying the benefits of cocoa drinking on the ...
... joint funding from the Engineering and Physical Science Research ... develop an innovative sensor to detect bacteria. The new ... fluorescent signal when it encounters bacteria, allowing scientists to ... methodologies. , The new technology will be ...
... childbearing age struggle with the heartache of infertility. Now there ... of a mutation in a gene that causes male infertility ... dominant mutation that leads specifically to infertility in a mammal ... for similar mutations in the DNA of infertile men. , ...
Cached Biology News:Cocoa 'vitamin' health benefits could outshine penicillin 2Researchers find gene mutation that causes infertility in male mice 2
Phospho-TAO2 (S181) Affinity Purified Polyclonal Ab Protein Family: Other Intracellular Kinases...
PEG 8000, Molecular Biology Grade...
... Deacetylase (HDAC) Antibody Sampler Kit Kit ... Catalog #2062, 40 ul Histone Deacetylase 3 ... Deacetylase 4 (HDAC4) Antibody, Catalog #2072, 40 ... #2082, 40 ul Histone Deacetylase 6 (HDAC6) ...
Immunogen: Synthetic Peptide: C N(185) D G T E F G G S I Y Q K(197) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: